Skip to main content
logo
From Bio Co.,Ltd (KOSDAQ:377220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,873.00
-77.00 (-3.95%)
At close: Oct 8, 2026

From Bio Co.,Ltd Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71,63972,16267,18266,72499,330135,103
Revenue Growth
8.25%7.41%0.69%-32.83%-26.48%-
Gross Profit
45,10341,55137,14545,95569,309102,104
Operating Income
-16,280-18,601-24,271-15,420897.0211,424
Net Income
-20,133-22,457-25,288-11,0763,24111,282
Earnings Per Share
-3556.24-3966.29-4465.00-1956.24570.002303.11
EPS Growth
-----75.25%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
763.782,2932,9766,44026,81044,104
Total Debt
35,46535,41126,85018,758485.67492.39
Net Cash (Debt)
-34,701-33,118-23,874-12,31826,32443,611
Net Cash Growth
-----39.64%-
Net Cash Per Share
-6129.47-5849.21-4215.35-2175.534649.218902.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7,757-10,072-14,700-20,845-2,023-1,175
Capital Expenditures
-713.74-1,104-893.42-16,656-13,589-8,781
Free Cash Flow
-8,471-11,176-15,593-37,501-15,613-9,956
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.96%57.58%55.29%68.87%69.78%75.58%
Operating Margin
-22.73%-25.78%-36.13%-23.11%0.90%8.46%
Pretax Margin
-25.41%-28.93%-37.05%-23.59%1.52%8.61%
Profit Margin
-28.10%-31.12%-37.64%-16.60%3.26%8.35%
FCF Margin
-11.82%-15.49%-23.21%-56.20%-15.72%-7.37%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----36.5613.68
PS Ratio
0.150.490.781.301.191.14